Clinical trial · Observational
Adaptation Strategies for Coping With the Impact of Sensory Alterations on Eating Behavior in Children With Cancer: A Qualitative Study From the Perspective of Children and Parents
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Childhood cancer is a serious and life-changing disease that affects thousands of children every year worldwide. In addition to the disease itself, cancer treatments such as chemotherapy often cause difficult side effects. Among these, changes in taste and smell are very common but still poorly understood in children. These sensory changes can make food taste unpleasant or smell different, leading children to eat less, avoid certain foods, or develop strong food aversions. As a result, many children with cancer experience weight loss, poor nutrition, and reduced quality of life, which can also affect how well they tolerate treatment. Research suggests that between 40% and 60% of children with cancer struggle to maintain good nutritional status during treatment. Taste and smell alterations play a major role in these difficulties. Children may experience nausea triggered by food smells, changes in food texture perception, or a loss of pleasure in eating. Parents often report feeling powerless and lacking clear guidance on how to help their child cope with these problems. While taste and smell disturbances have been widely studied in adults with cancer, much less is known about how children experience these changes and, importantly, how they and their families adapt to them. Parents play a key role in supporting their child's eating habits, but their perspectives may differ from the child's own experiences. This study aims to better understand how children undergoing chemotherapy and their parents perceive changes in taste, smell, and food texture, and how these changes affect eating behavior, emotions, and social life. Using individual semi-structured interviews, the study will explore the coping strategies used by children and parents to manage these sensory changes, both at home and in the hospital setting. By giving children and parents a voice, this research seeks to identify practical, real-life strategies that families find helpful. The results will contribute to improving nutritional support and guidance for children with cancer, with the ultimate goal of enhancing their well-being, quality of life, and treatment outcomes.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Eating Behavior Changes | — | UNRESOLVED | — |
| Smell Disorder | — | UNRESOLVED | — |
| Taste Alterations | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| No Intervention: Observational Cohort | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- children aged 6-17 years undergoing chemotherapy for a malignant hematological or solid tumor
- interventionNames
- Behavioral: No Intervention: Observational Cohort
- label
- one of the parent of the children included in the first group
- interventionNames
- Behavioral: No Intervention: Observational Cohort
Primary outcomes (1)
- measure
- coping strategies of the children and their parents for managment of sensory alterations and eating behaviour
- timeFrame
- at least 2 months after the beginning of the chemotherapy
- description
- Determine the coping strategies used by children and their parents to manage sensory alterations and eating behavior during chemotherapy. the method for the thematic analysis of qualitative data described by Braun and Clarke will be used
Secondary outcomes (7)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 6 Years
- Maximum age
- 17 Years
Show eligibility criteria text
Inclusion Criteria: Children: * Aged 6 to 17 years old on the day consent is obtained. * Diagnosed with a malignant hematological or oncological tumor. * Possessing sufficient verbal ability to participate in the interview planned for the study. * Having started chemotherapy treatment at least 2 months prior. * Agreeing to participate in the study. * Able to understand, read, and write French. * Affiliated with a social security system. Parents: * Be the parent or legal guardian of a child aged 6 to 17 inclusive, with cancer and undergoing chemotherapy. * Dated and signed informed consent. * Able to understand, read, and write French. Exclusion Criteria: \-
References
Publications (0)
Data not yet available